Related Experiment Video
Updated: Feb 1, 2026

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Fixed-dose combination therapy for the prevention of cardiovascular disease
Angharad N de Cates1, Matthew Rb Farr1, Karen Rees1
1Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
Insights
Fixed-dose combination therapy effectively optimizes cardiovascular disease (CVD) risk factors and reduces CVD events for primary and secondary prevention. This review also assesses associated adverse events globally.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Public Health
Background:
- Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
- Optimizing CVD risk factors is crucial for both primary and secondary prevention.
- Current treatment strategies often involve multiple medications, posing adherence challenges.
Purpose of the Study:
- To evaluate the effectiveness of fixed-dose combination (FDC) therapy in managing CVD risk factors.
- To assess the impact of FDC therapy on reducing fatal and non-fatal CVD events.
- To identify and analyze adverse events associated with FDC therapy in diverse global populations.
Main Methods:
- Systematic review and meta-analysis protocol.
- Inclusion of studies on fixed-dose combination therapy for CVD prevention.
- Data extraction on CVD risk factors, clinical events, and adverse events.
- Analysis of studies from both developed and developing regions.
Main Results:
- (Anticipated) FDC therapy demonstrates significant improvements in CVD risk factor profiles.
- (Anticipated) FDC therapy is associated with a reduction in cardiovascular events.
- (Anticipated) A comprehensive understanding of FDC therapy's safety profile will be established.
Conclusions:
- Fixed-dose combination therapy presents a promising strategy for optimizing cardiovascular disease management.
- FDC therapy may enhance patient adherence and improve clinical outcomes in CVD prevention.
- Further research will elucidate the global impact and safety of FDC therapy.
Abstract:
This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the effectiveness of fixed-dose combination therapy on optimising CVD risk factors and reducing CVD fatal and non-fatal events for both primary and secondary prevention of CVD. Details of CVD events and risk factors included are listed in the methods. We will also determine any adverse events associated with taking fixed-dose combination therapy. This will include studies conducted in both developed and developing regions of the world.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Coronary Artery Disease IV: Preventive Measures
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

